Skip to content
Screener

Omeros OMER Free cash flow margin

Discontinued — last reported Q3 '21

Free cash flow margin at other companies

Immunome logo
ImmunomeIMNM
-5,118.9%-8,601pp
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
-366.6%+1,421pp
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
-450.7%-524pp
Shattuck Labs, Inc. logo
Shattuck Labs, Inc.STTK
-4,124%-23,818pp
Dianthus Therapeutics logo
Dianthus TherapeuticsDNTH
-3,561.6%-6,956pp
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
-9,777.6%-10,759pp

Other financials

Income statement

See full
Revenue$9.9M—
Gross profit$29.7M—
Operating income-$40.9M-9.2%
Net income$56.1M+268%
EPS (diluted)-$0.59-20.4%

Balance sheet

See full
Cash & equivalents$1.9M-55.3%
Total debt$13.5M-30.3%
Total equity-$63.3M+70.3%
Total assets$286.2M+21.7%

Cash flow

See full
Operating cash flow-$14.5M+59.5%
CapEx--100%
Free cash flow-$14.5M+59.6%

Valuation

See full
Market cap$958.97M+245%
P/S10.7×—

Profitability

See full
Gross margin98.9%—
Operating margin-181.8%—
Net margin-136.6%—

Returns & leverage

See full
Return on equity86.6%—
Debt / equity0.3×-1.1×
Current ratio3×+1.9×

Where this comes from

Calculated from Omeros’s reported figures.

free cash flow/total revenue=-121.6%

Based on trailing twelve months.

The source filing: Omeros’s 10-Q, filed November 9, 2021. Open the filing →

Filed
Nov 9, 2021, 4:10 PM EST
Fiscal quarter
Q3 FY2021
Calendar quarter
Q3 2021
Accession
0001558370-21-015289

FAQ

What is Omeros's free cash flow margin?
Omeros (OMER) reported free cash flow margin of -121.6% in Q3 2021.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.

Ask your AI about Omeros's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude